Mark Wirtz

Mark Wirtz serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of scientific, diagnostic, and operational capabilities. He manages complex contracts enabling laboratory diagnostics, biomedical research, and data infrastructure critical to disease surveillance and rapid response initiatives. His portfolio centers on high-stakes, mission-critical procurements that ensure the CDC’s readiness to detect, analyze, and mitigate emerging health threats, with a focus on acquiring advanced analytical instruments, research services, and secure computing systems that underpin national public health operations. Wirtz maintains longstanding partnerships with leading contractors including General Dynamics Information Technology, Cepheid, GlaxoSmithKline, MRIGLOBAL, and the New York City Health & Hospitals Corp. These relationships reflect a preference for established industry leaders with proven expertise in infectious disease diagnostics, clinical research support, and large-scale public health data systems. His contracting approach emphasizes technical rigor, regulatory compliance, and performance-based outcomes, often involving long-term service agreements and complex scientific equipment procurement requiring specialized validation and calibration standards. Wirtz’s acquisition strategy shows no reliance on socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects a mission-driven prioritization of technical capability and operational readiness over socioeconomic preferences, aligning with the CDC’s urgent need for scalable, high-performance solutions during public health emergencies. His primary procurement focus lies in NAICS 541715 (research and development in life sciences), 334516 (analytical laboratory instrument manufacturing), and 518210 (data processing and computing infrastructure), underscoring deep expertise in procuring next-generation diagnostic platforms, precision lab equipment, and secure data systems essential for real-time epidemiological analysis and laboratory network modernization.